XML 107 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 728 $ 753
Accounts receivable, net 1,036 1,037
Inventories 936 1,014
Prepaid expenses and other current assets 42 38
Total current assets 2,742 2,842
Property, plant and equipment, net 6,912 6,595
Operating lease right-of-use assets 443 0
Goodwill 1,074 1,002
Other intangible assets, net 187 134
Equity Method Investments 1,112 253
Other assets, net 268 251
Total assets 13,261 11,602
Current liabilities    
Accounts payable 473 507
Accrued and other liabilities 768 676
Total current liabilities 1,241 1,183
Long-term debt, net 3,445 2,668
Deferred income taxes 1,255 1,159
Pension and other post-retirement benefits 360 337
Operating lease liabilities 355 0
Other liabilities 202 179
Total liabilities 6,858 5,526
Stockholders' equity    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and 134,651,380 shares issued at December 31, 2019 and 2018, respectively 1 1
Common stock, held in treasury, at cost; 6,266,609 and 6,183,125 shares at December 31, 2019 and 2018, respectively (377) (382)
Additional paid-in capital 553 556
Retained earnings 5,757 5,477
Accumulated other comprehensive loss (74) (62)
Total Westlake Chemical Corporation stockholders' equity 5,860 5,590
Noncontrolling interests 543 486
Total equity 6,403 6,076
Total liabilities and equity 13,261 11,602
Customer Relationships [Member]    
Current assets    
Customer relationships, net $ 523 $ 525